Pages that link to "Q38715468"
Jump to navigation
Jump to search
The following pages link to Amyotrophic lateral sclerosis and frontotemporal dementia: distinct and overlapping changes in eating behaviour and metabolism (Q38715468):
Displaying 38 items.
- Adiponectin levels in the serum and cerebrospinal fluid of amyotrophic lateral sclerosis patients: possible influence on neuroinflammation? (Q33582007) (← links)
- The tyrosine kinase receptor Tyro3 enhances lifespan and neuropeptide Y (Npy) neuron survival in the mouse anorexia (anx) mutation (Q33746241) (← links)
- Transcranial Magnetic Stimulation for the Assessment of Neurodegenerative Disease (Q38796845) (← links)
- Energy Homeostasis and Abnormal RNA Metabolism in Amyotrophic Lateral Sclerosis (Q39316849) (← links)
- A transgenic mouse expressing CHMP2Bintron5 mutant in neurons develops histological and behavioural features of amyotrophic lateral sclerosis and frontotemporal dementia (Q39665668) (← links)
- Cognition and eating behavior in amyotrophic lateral sclerosis: effect on survival (Q40719786) (← links)
- Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS. (Q41489347) (← links)
- Sweet food preference in amyotrophic lateral sclerosis (Q42335325) (← links)
- Amyotrophic Lateral Sclerosis, a Multisystem Pathology: Insights into the Role of TNFα. (Q42730558) (← links)
- What is "Hyper" in the ALS Hypermetabolism? (Q42730688) (← links)
- Energy expenditure in frontotemporal dementia: a behavioural and imaging study. (Q47136369) (← links)
- Lipid Metabolism and Survival Across the Frontotemporal Dementia-Amyotrophic Lateral Sclerosis Spectrum: Relationships to Eating Behavior and Cognition (Q47908351) (← links)
- Serum C-Peptide, Visfatin, Resistin, and Ghrelin are Altered in Sporadic and GRN-Associated Frontotemporal Lobar Degeneration (Q47922942) (← links)
- Hypermetabolism appears to be an adverse prognostic biomarker in amyotrophic lateral sclerosis: a potential for therapeutic intervention? (Q48303760) (← links)
- Cardiometabolic health and risk of amyotrophic lateral sclerosis. (Q48379805) (← links)
- Music models aberrant rule decoding and reward valuation in dementia (Q49547971) (← links)
- Hypothalamic Alterations in Neurodegenerative Diseases and Their Relation to Abnormal Energy Metabolism. (Q49659203) (← links)
- Physiological changes in neurodegeneration - mechanistic insights and clinical utility. (Q51760271) (← links)
- Anthropometric measures are not accurate predictors of fat mass in ALS. (Q52097288) (← links)
- Energy metabolism in ALS: an underappreciated opportunity? (Q52651163) (← links)
- Progress and Challenges in Frontotemporal Dementia Research: A 20-Year Review. (Q53441607) (← links)
- Circadian Rhythm Dysfunction Accelerates Disease Progression in a Mouse Model With Amyotrophic Lateral Sclerosis. (Q55263095) (← links)
- Association of Serum Retinol-Binding Protein 4 Concentration With Risk for and Prognosis of Amyotrophic Lateral Sclerosis (Q60637542) (← links)
- Eating peptides: biomarkers of neurodegeneration in amyotrophic lateral sclerosis and frontotemporal dementia (Q64262814) (← links)
- Exploration of attractor modules for sporadic amyotrophic lateral sclerosis via systemic module inference and attract method (Q64271172) (← links)
- Association Between Premorbid Body Mass Index and Amyotrophic Lateral Sclerosis: Causal Inference Through Genetic Approaches. (Q64891664) (← links)
- Energy balance: yet another challenge for neurodegenerative diseases (Q87179585) (← links)
- Hypermetabolism in ALS is associated with greater functional decline and shorter survival (Q88506724) (← links)
- Low Serum High-Density Lipoprotein Cholesterol Levels Associate with the C9orf72 Repeat Expansion in Frontotemporal Lobar Degeneration Patients (Q90333276) (← links)
- Exploring targets and therapies for amyotrophic lateral sclerosis: current insights into dietary interventions (Q90531525) (← links)
- Body mass index and survival from amyotrophic lateral sclerosis: A meta-analysis (Q90624869) (← links)
- Existing and Emerging Metabolomic Tools for ALS Research (Q91811242) (← links)
- Neurodegenerative Diseases - Is Metabolic Deficiency the Root Cause? (Q91972707) (← links)
- Identification of TYW3/CRYZ and FGD4 as susceptibility genes for amyotrophic lateral sclerosis (Q92223409) (← links)
- Regulation of Brain Cholesterol: What Role Do Liver X Receptors Play in Neurodegenerative Diseases? (Q92527693) (← links)
- Neural networks associated with body composition in frontotemporal dementia (Q92957281) (← links)
- Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing (Q97692894) (← links)
- Glutamate-glutamine homeostasis is perturbed in neurons and astrocytes derived from patient iPSC models of frontotemporal dementia (Q99415511) (← links)